Saxsons Group — India's trusted nuclear medicine, radiotherapy, oncosurgery, dosimetry and cyclotron supplier since 1986

All research papers

2219 approved papers, newest first · showing 361–420.Search instead →

  1. 20 Aug 2026· Medical Physics· QA & dosimetry· Free full text
    Dose modeling of superficial brachytherapy applicator geometries using multiple radioisotopes
    Jin Jegal et al.
  2. 20 Aug 2026· Frontiers in Oncology· Therapeutic· Free full text
    Single-cell transcriptomics and a boundary wound model reveal temporal decoupling and microenvironmental heterogeneity in radiation-induced fibrosis
    Bingyue Cao et al.
  3. 20 Aug 2026· Pediatric Radiology· Diagnostic· QA & dosimetry· Free full text
    Radiographic imaging in pediatric suspected foreign body ingestion: potential for dose reduction through collimation and exposure strategies
    Max-Johann Sturm et al.
  4. 20 Aug 2026· Physics in Medicine and Biology· Diagnostic· Free full text
    A Monte Carlo positronium decay source model with multiple annihilation channels in GATE
    Wojciech Krzemien et al.
  5. 20 Aug 2026· Frontiers in Oncology· Diagnostic· Free full text
    Visualization-driven digital technologies in oncology: current applications, technological advances, and future directions
    Xiaoxia Duan et al.
  6. 20 Aug 2026· European Archives of Oto-Rhino-Laryngology· SRS / intracranial· Therapeutic· Free full text
    Management strategies for vestibular schwannomas in patients with NF2-related schwannomatosis: a systematic review
    Helbert de Oliveira Manduca Palmiero et al.
  7. 20 Aug 2026· BMC Cancer· SRS / intracranial· Therapeutic· Free full text
    Single-fraction versus two-fraction stereotactic radiosurgery for brain oligometastases: a multicenter propensity score-matched analysis with exploratory assessment of biologically effective dose and primary tumor control status
    Shenghong Wu et al.
  8. 20 Aug 2026· Scientific Reports· QA & dosimetry· Free full text
    Knowledge-based VMAT planning by using the dosimetric features for cervical cancer
    Zhimin Li et al.
  9. 20 Aug 2026· Physics in Medicine and Biology· Therapeutic· QA & dosimetry· Free full text
    Biologically optimized 3D range modulators for fast conformal carbon ion therapy: in vitro validation, treatment planning, and robustness analysis
    S Ahn et al.
  10. 20 Aug 2026· Seminars in Radiation Oncology· QA & dosimetry· Free full text
    Redundancy Strategies for Cyber Resilience in Radiation Oncology
    Baoshe Zhang et al.
  11. 20 Aug 2026· Frontiers in Immunology· Diagnostic· Free full text
    Imaging the fate of CAR-T cells in vivo
    Hongyi Wang et al.
  12. 20 Aug 2026· Journal of Nuclear Medicine· Ga-68 PSMA PET· Diagnostic· Free full text
    PSMA PET Imaging for Prostate Cancer Recurrence After Minimally Invasive Focal Therapy: A Single-Center Retrospective Study
    Mahbod Jafarvand et al.
  13. 20 Aug 2026· Cyclotron production· Diagnostic· Radiopharmacy· Free full text
    Feasibility and Safety of 68Ga-PSMA-11 PET/CT Using Cyclotron-Produced 68Ga in Patients with Prostate Cancer
    Saruta M et al.
  14. 20 Aug 2026· Journal of controlled release : official journal of the Controlled Release Society· Lu-177 FAPI· Theranostic· Free full text
    Preclinical and first-in-human pilot evaluation of ¹⁷⁷Lu-DOTA-7ND for fibroblast activation protein-α-targeted radionuclide imaging and therapy.
    Liang Y et al.
  15. 20 Aug 2026· Journal of nuclear medicine : official publication, Society of Nuclear Medicine· Lu-177 FAPI· Theranostic· Free full text
    Safety, Biodistribution, and Dosimetry of FAP and Integrin αvβ₃ Dual-Targeting Radioligand ¹⁷⁷Lu-DOTA-FAPI-RGD: Preclinical Validation and First-in-Human Study in Patients with Advanced Adenocarcinomas.
    Xiang J et al.
  16. 20 Aug 2026· European Urology Open Science· Diagnostic· Free full text
    Comparative assessment of METastasis Reporting and Data System for Prostate Cancer versus Prostate Cancer Clinical Trials Working Group 3 Criteria in assessing treatment response in patients with metastatic castration-resistant prostate cancer
    Luca Russo et al.
  17. 20 Aug 2026· Advances in Radiotherapy & Nuclear Medicine· QA & dosimetry· Free full text
    A commissioning workflow for quantitative ¹⁷⁷Lu SPECT/CT across different Siemens scanner–reconstruction configurations
    Leonardo Lampertico et al.
  18. 20 Aug 2026· Journal of nuclear medicine : official publication, Society of Nuclear Medicine· Ga-68 PSMA PET· Theranostic· Free full text
    The Global Theranostics Access Gap: Real-World Disparities in PSMA PET/CT and ¹⁷⁷Lu-PSMA Therapy Between Centers in Brazil and Europe.
    Cerci JJ et al.
  19. 19 Aug 2026· International journal of molecular sciences· Radiopharmaceutical QC· Radiopharmacy· Free full text
    Comparative Study of NOTA-Derived Chelators: Synthesis, Al¹⁸F/¹⁷⁷Lu Radiolabeling and Computational Analysis.
    Dhimen A et al.
  20. 19 Aug 2026· International journal of molecular sciences· Radiopharmaceutical QC· Radiopharmacy· Free full text
    Development and Characterization of the PSMA-Expressing CT26-PSMA Cell Line as a Rapid Preclinical Platform for ⁶⁸Ga-Labeled PSMA-Targeted Radioconjugates.
    Lunev AS et al.
  21. 19 Aug 2026· Patient preference and adherence· I-131 therapy· Therapeutic· Free full text
    Knowledge, Attitudes, and Practices Regarding Iodine-131 Therapy and Their Association with Depression and Anxiety Among Postoperative Thyroid Cancer Patients Undergoing I-131 Treatment.
    Yang W et al.
  22. 19 Aug 2026· medRxiv· Diagnostic· Free full text
    Simulation of low-dose PET imaging protocols for assessment of pancreatic beta-cell mass in pediatric type 1 diabetes
    Behzad Zareian et al.
  23. 19 Aug 2026· Radiation protection dosimetry· Personal / occupational dosimetry· Radiation safety· Free full text
    Occupational effective doses for regional and university hospitals in Albania (2021-2025): optimization and statistical analysis.
    Gega E et al.
  24. 19 Aug 2026· Frontiers in Oncology· SBRT delivery· Therapeutic· Free full text
    Single-fraction stereotactic radiotherapy for lung malignancies: preliminary results of a mono-institutional experience
    Francesco Cuccia et al.
  25. 19 Aug 2026· Scientific Reports· Therapeutic· Free full text
    Nationwide real-world analysis of neuroendocrine tumors in Japan using the JMDC claims database
    Ryogo Minamimoto et al.
  26. 19 Aug 2026· Frontiers in Oncology· Ga-68 PSMA PET· Theranostic· Free full text
    Beyond treatment eligibility: rethinking theranostic targets
    Christopher Montemagno et al.
  27. 18 Aug 2026· Immunobiology· Therapeutic· Free full text
    MARCO is associated with radiosensitivity in lung cancer through modulation of Hippo signaling
    Zhenfeng Zong et al.
  28. 18 Aug 2026· Repository of the University of Ljubljana (University of Ljubljana)· QA & dosimetry· Free full text
    Patient safety in radiotherapy
    Lara Žarkovič et al.
  29. 18 Aug 2026· Medical Physics· Diagnostic· Free full text
    Dual‐view scout scans with deep learning for ultra‐low dose attenuation correction in PET
    Florence M. Muller et al.
  30. 18 Aug 2026· Nanoscale· Diagnostic· Free full text
    Synthesis and preclinical validation of 5HT1A receptor-targeted carbon dots functionalized with Gd3+ and 99mTc as a multi-modal SPECT and MRI probe for molecular imaging.
    Gautam D et al.
  31. 18 Aug 2026· Journal of Applied Clinical Medical Physics· OSL dosimetry· QA & dosimetry· Free full text
    Impact of X‐ray beam quality on organ‐absorbed dose in chest CT: Evaluation using spectral analysis and beam‐shaping filters
    Yusuke Ito et al.
  32. 18 Aug 2026· Artificial intelligence in medicine· Diagnostic· Free full text
    DiffCAS: Inference-time CT-free diffusion model for physics-aware multi-slice attenuation correction in cardiac SPECT.
    Vu HM et al.
  33. 18 Aug 2026· International journal of radiation oncology, biology, physics· SBRT delivery· Therapeutic· Free full text
    Forecasting Time-Dependent Radiation Induced Lymphocyte Depletion in a Clinical Trial on Early-Stage Lung Cancer.
    Nguyen C et al.
  34. 18 Aug 2026· Future oncology (London, England)· SBRT delivery· Therapeutic· Diagnostic· Free full text
    PSMA-PET/mpMRI-guided focal dose-escalated stereotactic body radiotherapy for localized prostate cancer: study protocol for a prospective, randomized controlled trial.
    Peng WS et al.
  35. 18 Aug 2026· Therapeutic advances in medical oncology· SBRT delivery· Therapeutic· Free full text
    Stereotactic radiotherapy for rib metastases from prostate cancer: A multicenter real-world analysis of local control, pain response, and treatment tolerance (RIBRISK).
    Bilski M et al.
  36. 18 Aug 2026· Physics in Medicine and Biology· SRS / intracranial· Therapeutic· Free full text
    A 2π solid angle-based heuristic framework for non-coplanar VMAT in multiple brain metastases
    Siyang Huang et al.
  37. 18 Aug 2026· Bioorganic chemistry· Radiopharmaceutical QC· Radiopharmacy· Free full text
    Radioiodination, biological distribution, and docking study of diosmetin as a potential radiotracer for infection detection.
    Challan SB et al.
  38. 18 Aug 2026· Clinical and Experimental Medicine· Radiation safety· Free full text
    Radium - from discovery to the present day – narrative review
    Angelika Edyta Charkiewicz et al.
  39. 18 Aug 2026· Clinical cancer research : an official journal of the American Association for Cancer Research· Ac-225 alpha therapy· Therapeutic· Free full text
    Efficacy of actinium-225-labeled fully human anti-MUC-16 radioimmunoconjugate against MUC-16-positive ovarian and pancreatic ductal adenocarcinoma xenograft models.
    Babeker H et al.
  40. 18 Aug 2026· Journal of Nuclear Medicine Technology· Lu-177 DOTATATE· Radiation safety
    Radiation Exposure from Patients During 177 Lu-DOTATATE Infusions
    S.V. Tipnis et al.
  41. 18 Aug 2026· European Radiology Experimental· Ac-225 alpha therapy· Therapeutic· Free full text
    Evaluation of the safety and efficacy of 225Ac-PSMA-CY313 in metastatic castration-resistant prostate cancer: preliminary results
    Hao Zhang et al.
  42. 18 Aug 2026· EJNMMI Research· Ga-68 PSMA PET· Theranostic· Free full text
    Evaluation of the biodistribution of [99mTc]Tc-PSMA-GCK01 SPECT/CT in a prospective, intraindividual comparison with [68Ga]PSMA-11 PET/CT for phenotyping in mCRPC prior to PSMA-targeted radioligand therapy
    E Novruzov et al.
  43. 17 Aug 2026· Clinical and translational radiation oncology· SBRT delivery· Therapeutic· Free full text
    Post-SABR early PSA density kinetics in androgen deprivation therapy-naïve patients: early landmark models for long-term biochemical recurrence-free survival.
    Greco C et al.
  44. 17 Aug 2026· Clinical nuclear medicine· Lu-177 FAPI· Diagnostic
    The Potential Role of 99m Tc-FAPI SPECT/CT in the Staging of Mucinous Appendiceal Adenocarcinoma.
    Rezaei Borujerdi N et al.
  45. 17 Aug 2026· DNA repair· Radiation safety· Free full text
    Neuron irradiation of Caenorhabditis elegans by protons triggers base excision repair pathway with limited effect on behaviour
    A. Sleiman et al.
  46. 17 Aug 2026· The European Physical Journal Plus· Personal / occupational dosimetry· QA & dosimetry· Free full text
    Investigating the feasibility of X-ray incident angle determination using radiophotoluminescent glass dosimeter
    Soheil Aghabaklooei et al.
  47. 17 Aug 2026· MedComm· Therapeutic· Free full text
    Abscopal Effect in Radiation Therapy: The Immune Mechanisms and Clinical Advances
    Yihong Dong et al.
  48. 17 Aug 2026· Journal of Neurosurgery Case Lessons· Thermoplastic masks· Therapeutic· Free full text
    Hybrid frame-mask fixation for Gamma Knife radiosurgery of an extracranial vagal schwannoma: illustrative case
    Victor Goulenko et al.
  49. 17 Aug 2026· Nuclear Engineering and Technology· Linac QA· QA & dosimetry· Free full text
    Field- and filter-dependent tissue-maximum ratios for 6 MV photon
    O. El mouden et al.
  50. 17 Aug 2026· Frontiers in Immunology· Therapeutic· Free full text
    Optimizing immunotherapy–radiotherapy synergy in triple-negative breast cancer: mechanisms, clinical evidence, and therapeutic windows
    Lu Wang et al.
  51. 17 Aug 2026· Journal of Clinical Investigation· Therapeutic· Free full text
    Radiotherapy and immunotherapy in cancer treatment: mechanisms of clinical synergy
    Lu Lu et al.
  52. 17 Aug 2026· European Journal of Nuclear Medicine and Molecular Imaging· Diagnostic· Free full text
    Prognostic relevance of [18F]FDG PET/CT in triple-negative breast cancer: Results from the triple negative (TRINE)-PET trial
    Luca Urso et al.
  53. 17 Aug 2026· Bioorganic & medicinal chemistry· Ga-68 PSMA PET· Radiopharmacy· Free full text
    PSMA binding of carbamate-containing peptidomimetics influenced by side chain length and stereocenter configuration in preclinical prostate cancer model.
    Roxin Á et al.
  54. 17 Aug 2026· EJNMMI Physics· Therapeutic· Free full text
    Performance evaluation of a position-sensitive SiPM-based gamma camera for intraoperative imaging
    Aramis Raiola et al.
  55. 17 Aug 2026· Radiation protection dosimetry· Radiation safety· Free full text
    Establishment of preliminary diagnostic reference levels for 18F-FDG PET/CT in adult lymphoma in Costa Rica.
    Madrigal JAM et al.
  56. 17 Aug 2026· Pediatric blood & cancer· Patient-specific QA· QA & dosimetry· Therapeutic· Free full text
    Feasibility, Treatment Planning, and Clinical Results of VMAT-Based Total Body Irradiation for Pediatric Patients: Single-Center Experience.
    Mico S et al.
  57. 17 Aug 2026· PloS one· I-131 therapy· Therapeutic· Free full text
    The effects of stimulated thyroglobulin/ thyroid-stimulating hormone ratio and N1b status on the efficacy of the first I-131 treatment in patients with differentiated thyroid cancer.
    Mayurasakorn S et al.
  58. 17 Aug 2026· European journal of nuclear medicine and molecular imaging· Ac-225 alpha therapy· Theranostic· Free full text
    Prognostic value of the dual-tracer PET score (NETPET) in neuroendocrine tumors with [²²⁵Ac]Ac-DOTATATE therapy.
    Liu Y et al.
  59. 17 Aug 2026· The oncologist· Lu-177 PSMA· Therapeutic· Free full text
    An Assessment of Time Toxicity in Patients Receiving [177Lu]Lu-PSMA-617 for Metastatic Castration-Resistant Prostate Cancer (mCRPC).
    Scharf Z et al.
  60. 16 Aug 2026· Thyroid· I-131 therapy· Therapeutic
    Second Primary Malignancies Among Pediatric and Young Adult Survivors of Differentiated Thyroid Cancer: Real-World Evidence.
    Bello R et al.